Polycystic Ovary Syndrome and Endometrial Cancer
The DOI matches its Crossref record.
Abstract
An association between polycystic ovary syndrome (PCOS) and endometrial carcinoma was first suggested in 1949. Since then, several studies have been published that appear to support this association, and it is common practice among gynecologists and physicians to prescribe hormonal treatment to reduce this perceived risk, although there is no consensus as to the subgroup of PCOS in whom this is required. The mechanism(s) underlying any association are also unclear, but it is again widely assumed that chronic anovulation, which results in continuous estrogen stimulation of the endometrium unopposed by progesterone, is a major factor. However, obesity, hyperinsulinemia, and hyperandrogenism, which are also features of PCOS, are risk factors for endometrial carcinoma, but it does not necessarily follow that the incidence or mortality from endometrial cancer is increased in women with the syndrome. Potential strategies to prevent endometrial cancer in PCOS women are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488
“Malignancy Women with PCOS are at an increased risk of endometrial abnormalities, including carcinomas, and should be followed carefully for these disorders because hyperinsulinemia due to insulin resistance and hyperestrogenemia from ovulatory dysfunction promote endometrial cell proliferation”
BackgroundPalomba, S., Falbo, A., Zullo, F., & Orio, F. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0030 · Cited by 426
Roles of oxidative stress in polycystic ovary syndrome and cancers
Zuo, T., Zhu, M., & Xu, W. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8589318 · Cited by 319
Tehrani, F., Simbar, M., Tohidi, M., Hosseinpanah, F., & Azizi, F. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-39 · Cited by 290
Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update
Abraham Gnanadass, S., Divakar Prabhu, Y., & Valsala Gopalakrishnan, A. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05951-2 · Cited by 272
The Australian Ovarian Cancer Study Group and The Australian National Endometrial Cancer Study Group, Fearnley, E. J., Marquart, L., Spurdle, A. B., Weinstein, P., & Webb, P. M. (2010) · Cancer Causes & Control · doi:10.1007/s10552-010-9658-7 · Cited by 162
“ten exposed cases and was largely ignored in the discussion of that paper and in subsequent review papers [3, 24], which have focussed on the weaker association between infertility due to ovarian factors and endometrial cancer risk [14].”
BackgroundRosiglitazone and Risk of Cancer
Monami, M., Lamanna, C., Marchionni, N., & Mannucci, E. (2008) · Diabetes Care · doi:10.2337/dc07-2308 · Cited by 97
“Interestingly, no reduction of risk for cancer of the female genital tract was detected in rosiglitazone-treated patients, although the drug is used in the treatment of polycystic ovary syndrome (20), which is a known risk factor for these malignancies (21).”
BackgroundRisk of endometrial cancer in patients with polycystic ovarian syndrome: A meta‑analysis
Johnson, J.-E., Daley, D., Tarta, C., & Stanciu, P. (2023) · Oncology Letters · doi:10.3892/ol.2023.13754 · Cited by 78
“An increased risk of endometrial cancer has been reported in females with PCOS (1,10), although the underlying mecha‑ nism remains elusive (10).”
Oncology and Pharmacogenomics Insights in Polycystic Ovary Syndrome: An Integrative Analysis
Yumiceba, V., López-Cortés, A., Pérez-Villa, A., Yumiseba, I., Guerrero, S., García-Cárdenas, J. M., Armendáriz-Castillo, I., Guevara-Ramírez, P., Leone, P. E., Zambrano, A. K., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.585130 · Cited by 40
“…via estrogen in the endometrium unopposed by the inhibitory effects of progesterone, overproduction of luteinizing hormone (LH), upregulation of aromatase activity, elevated insulin-like factor-1 (IGF-1) concentrations, and insulin resistance (IR) may represent risk factors for EC (10, 33).”
Coexistence of polycystic ovary syndrome and endometriosis in women with infertility
Holoch, K. J., Savaris, R. F., Forstein, D. A., Miller, P. B., Higdon, H. L., Likes, C. E., & Lessey, B. A. (2014) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.5301/je.5000181 · Cited by 30
“Visually suspected, yes/no (%; 95% CI) 14/97 (12; 7-20) 77/27 (72; 62-79) <0.”
BackgroundUterine Morphology and Peristalsis in Women with Polycystic Ovary Syndrome
Leonhardt, H., Gull, B., Kishimoto, K., Kataoka, M., Nilsson, L., Janson, P. O., Stener-Victorin, E., & Hellström, M. (2012) · Acta Radiologica · doi:10.1258/ar.2012.120384 · Cited by 29
Atiomo, W., Read, A., Golding, M., Silcocks, P., Razali, N., Sarkar, S., Hardiman, P., & Thornton, J. (2009) · Contemporary Clinical Trials · doi:10.1016/j.cct.2009.05.001 · Cited by 28
“the United Kingdom) [2] have been shown to have significant risk factors for endometrial cancer including insulin resistance [3], raised body mass index (BMI), anovulatory infertility and high circulating oestrogen and testosterone levels [4].”
BackgroundSelf-citation
Metadata
- Authors
- Navaratnarajah, R., Pillay, O., & Hardiman, P.
- Venue
- Seminars in Reproductive Medicine
- Publisher
- Georg Thieme Verlag KG
- Published
- 2008-01
- Volume
- 26
- Issue
- 1
- Pages
- 062-071
- ISSN
- 1526-4564 (ISSN-L)
- 1526-8004
- OpenAlex
- W2065768130
- Cited by
- 136
- References
- 0
- FWCI
- 11.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.